Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemia

  • Fujishima, Naohito; 
  • Uchida, Toshiki; 
  • Onishi, Yasushi; 
  • Jung, Chul Won; 
  • Goh, Yeow Tee; 
  • 외 9명
Citations

WEB OF SCIENCE

8
Citations

SCOPUS

13

초록

Inotuzumab ozogamicin (InO) is a targeted treatment for adults with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). InO was previously studied in INO-VATE, an international, open-label, randomized phase 3 trial comparing InO against standard of care (SoC). In the present subgroup analysis, we evaluated outcomes in the 55 Asian patients who were randomized in INO-VATE (31 InO and 24 SoC). Complete remission (CR) or CR with incomplete hematologic recovery (CRi) was achieved in 22/31 patients treated with InO versus 5/24 treated with SoC. In the InO arm, more of the patients achieving CR/CRi were minimal residual disease (MRD)-negative (17/22 versus 1/5), and more patients proceeded directly to hematopoietic stem cell transplantation (15/31 versus 3/24). Median overall survival for the respective arms was 5.8 versus 3.9 months (hazard ratio 0.67; 97.5% CI 0.28, 1.62). In the safety analysis (n = 51), the most common adverse events were hematologic. Sinusoidal obstruction syndrome was reported in five InO patients and one SoC patient. In conclusion, Asian patients with relapsed or refractory B-cell ALL experienced improved efficacy with InO versus SoC, with an efficacy and safety profile consistent with results of the overall INO-VATE population.

키워드

Inotuzumab ozogamicin; Asian; Relapsed; refractory; Acute lymphoblastic leukemia; JAPANESE PATIENTS; ADULT PATIENTS; HYPER-CVAD; PHASE-II; CHEMOTHERAPY; DISEASE; IMATINIB; COMBINATION; MANAGEMENT; ANTIBODY
제목
Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemia
저자
Fujishima, Naohito; Uchida, Toshiki; Onishi, Yasushi; Jung, Chul Won; Goh, Yeow Tee; Ando, Kiyoshi; Wang, Ming Chung; Ono, Chiho; Matsumizu, Miyako; Paccagnella, M. Luisa; Sleight, Barbara; Vandendries, Erik; Fujii, Yosuke; Hino, Masayuki
DOI
10.1007/s12185-019-02749-0
발행일
2019-12
유형
Article
저널명
International Journal of Hematology
권
110
호
6
페이지
709 ~ 722